Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

ClinicalTrials.gov ID: NCT00054873

Public ClinicalTrials.gov record NCT00054873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 9:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00054873
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Chiron Corporation
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • tezacitabine Drug
  • 5-fluorouracil Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2003
Primary completion
Not listed
Completion
Nov 30, 2004
Last update posted
Jul 10, 2006

2003 – 2004

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
ACRC/Arizona Clinical Research Center Tucson Arizona 85712
Glendale Memorial Hospital Glendale California 91204
USC/Norris Comprehensive Cancer Center Los Angeles California 90033
Tower Hematology Oncology Medical Group Los Angeles California 90048
Comprehensive Cancer Center at DRMC Palm Springs California 92262
Desert Regional Medical Center Palm Springs California 92262
Sharp Clinical Oncology Research San Diego California 92123
UCSF Comprehensive Cancer Center San Francisco California 94115-1705
Cancer Institute Medical Group Santa Monica California 90404
Denver VAMC Denver Colorado 80220
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612-9497
Memorial Regional Comprehensive Cancer Center Weston Florida 33326
Northwestern University, Feinberg School of Medicine, Division of Hematology/Oncology Chicago Illinois 60611
The University of Chicago Chicago Illinois 60637
Ochsner Clinic Foundation New Orleans Louisiana 70121
LSU Health Sciences Center, Dept. of Medicine, Hematology/Oncology Shreveport Louisiana 77130
Massachusetts General Hospital Boston Massachusetts 02114
University of Michigan Medical Center Ann Arbor Michigan 48109-0922
Josephine Ford Cancer Center, Henry Ford Health System Detroit Michigan 48202
Kansas City Oncology and Hematology Group Kansas City Missouri 64111
Washington University School of Medicine St Louis Missouri 63110
Duke University Medical Center Durham North Carolina 27710
Cleveland Clinic Foundation Cleveland Ohio 44195
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
The Sarah Cannon Cancer Center, Tennessee Oncology Nashville Tennessee 37203
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232
University of Texas, MD Anderson Cancer Center Houston Texas 77030
Swedish Cancer Institute Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00054873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2006 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00054873 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →